Tissue Regenix Group

Tissue Regenix was established in May 2006 and is dedicated to the development of clinical solutions to address the chronic shortfalls in donor tissue availability in areas such as Vascular and Orthopaedic medicine. There is a well established clinical need for more donor tissue for many surgical procedures. Tissue Regenix will develop and commercialise acellular tissue repair products to meet this need, to ultimately benefit patients.
Type
Public
HQ
Swillington, GB
Founded
2006
Employees
60 (est)
Tissue Regenix Group was founded in 2006 and is headquartered in Swillington, GB

Tissue Regenix Group Locations

Swillington, GB
San Antonio, US

Tissue Regenix Group Metrics

Tissue Regenix Group Summary

Market capitalization

£133 B

Closing share price

£0.173
Tissue Regenix Group's latest market capitalization is £133 B.

Tissue Regenix Group Financials

Tissue Regenix Group's revenue was £816 K in FY, 2016 which is 716.0% increase from the previous period.
FY, 2014FY, 2015FY, 2016

Revenue

£6 K£100 K£816 K

Revenue growth, %

1566.7%716.0%

Cost of sales

£32 K£154 K

Gross profit

£68 K£662 K

Gross profit Margin, %

68.0%81.1%

Operating expense total

£8.44 M£10.9 M

Tissue Regenix Group Market Value History

27% of current employees of Tissue Regenix Group are female and 73% are male.

Tissue Regenix Group Company Life

You may also be interested in